US BANCORP \DE\ - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 220 filers reported holding REVANCE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$37,564
-53.8%
3,275
+1.9%
0.00%
Q2 2023$81,372
-36.5%
3,215
-19.2%
0.00%
Q1 2023$128,132
-73.7%
3,978
-84.9%
0.00%
-100.0%
Q4 2022$486,993
+6.3%
26,381
+55.2%
0.00%0.0%
Q3 2022$458,000
+3716.7%
16,999
+1895.2%
0.00%
Q2 2022$12,000
-70.7%
852
-59.5%
0.00%
Q1 2022$41,0000.0%2,106
-16.8%
0.00%
Q4 2021$41,000
+412.5%
2,531
+820.4%
0.00%
Q3 2021$8,0000.0%2750.0%0.00%
Q2 2021$8,0000.0%2750.0%0.00%
Q1 2021$8,000
+14.3%
275
+7.0%
0.00%
Q4 2020$7,000
+16.7%
2570.0%0.00%
Q3 2020$6,0000.0%2570.0%0.00%
Q2 2020$6,000
+100.0%
257
+29.8%
0.00%
Q1 2020$3,0000.0%1980.0%0.00%
Q4 2019$3,000
-70.0%
198
-73.4%
0.00%
Q3 2019$10,000
+42.9%
743
+36.3%
0.00%
Q2 2019$7,000
-36.4%
545
-19.0%
0.00%
Q1 2019$11,000
+10.0%
673
+34.6%
0.00%
Q4 2018$10,000
-47.4%
500
-34.2%
0.00%
Q3 2018$19,000
-9.5%
7600.0%0.00%
Q2 2018$21,000
+40.0%
760
+52.0%
0.00%
Q1 2018$15,0005000.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
NovaQuest Capital Management, L.L.C. 1,558,426$48,000,00065.50%
Essex Woodlands Management, Inc. 3,842,047$118,335,00025.90%
Rhenman & Partners Asset Management AB 203,181$6,258,0000.77%
EAM Global Investors LLC 44,898$1,383,0000.72%
Fosun International Ltd 319,313$9,835,0000.62%
EAM Investors, LLC 113,096$3,483,0000.58%
ArrowMark Colorado Holdings LLC 1,735,699$53,460,0000.53%
Perceptive Advisors 618,957$19,064,0000.53%
ESSEX INVESTMENT MANAGEMENT CO LLC 111,360$3,430,0000.45%
Schonfeld Strategic Advisors LLC 83,700$2,578,0000.19%
View complete list of REVANCE THERAPEUTICS INC shareholders